Top Clinical Trials companies in Norway by Net Cash Used For Investing Activities
This ranking features the top 3 Clinical Trials companies in Norway ranked by Net Cash Used For Investing Activities, totaling a Net Cash Used For Investing Activities of USD -298.15 K, for February 07, 2025.
Norway
Clinical Trials
Net Cash Used For Investing Activities
Frequently Asked Questions
-
Which Clinical Trials company in Norway has the highest Net Cash Used For Investing Activities ?
The Clinical Trials company in Norway with the highest Net Cash Used For Investing Activities is BerGenBio ASA (Oslo Stock Exchange: BGBIO.OL) at USD 299.92 K.
-
Which Clinical Trials company in Norway has the lowest Net Cash Used For Investing Activities ?
The Clinical Trials company in Norway with the lowest Net Cash Used For Investing Activities is Gentian Diagnostics ASA (Oslo Stock Exchange: GENT.OL) at USD -478.80 K.
-
What are the top 10 Clinical Trials companies in Norway by Net Cash Used For Investing Activities ?
The top 10 Clinical Trials companies in Norway by Net Cash Used For Investing Activities are BerGenBio ASA, Lifecare AS and Gentian Diagnostics ASA.
-
What are the bottom 10 Clinical Trials companies in Norway by Net Cash Used For Investing Activities ?
The bottom 10 Clinical Trials companies in Norway by Net Cash Used For Investing Activities are Gentian Diagnostics ASA, Lifecare AS and BerGenBio ASA.
